'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Sakar Healthcare Limited
SAKAR (NSE) · SAKAR (BSE 200519) · ISIN INE732S01012 · Pharmaceuticals · listed 2019
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹72.97 cr and profit after tax ₹10.28 cr. Revenue was 38.4% higher than in Q1 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹72.97 cr | ₹10.28 cr | 4.62 | 24 Jul 2026 |
| Q4 FY26 standalone | ₹71.1 cr | ₹11.02 cr | 4.96 | 12 May 2026 |
| Q3 FY26 standalone | ₹70.34 cr | ₹10.25 cr | 4.59 | 5 Feb 2026 |
| Q2 FY26 standalone | ₹57.56 cr | ₹4.54 cr | 2.03 | 7 Nov 2025 |
| Q1 FY26 standalone | ₹52.74 cr | ₹4.67 cr | 2.11 | 28 Jul 2025 |
| Q4 FY25 standalone | ₹50.24 cr | ₹5.76 cr | 2.66 | 15 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹346.08 cr | ₹46.02 cr | ₹515.81 cr |
| 31 Mar 2026 standalone | ₹324.54 cr | ₹55.3 cr | ₹481.09 cr |
| 30 Sep 2025 standalone | ₹303.34 cr | ₹71.86 cr | ₹448.68 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 51.70% | 12.34% | 11.92% | 48.30% |
Latest filings
- Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 23 October 2026 · NSE
- Annual Report FY2025-26 (New) 27 August 2026 · NSE
- Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call. 3 August 2026 · NSE
- Sakar Healthcare Limited has informed the Exchange about Link of Recording 29 July 2026 · NSE
- Sakar Healthcare Limited has informed the Exchange about Investor Presentation 28 July 2026 · NSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Ajanta Pharma Limited
- Alivus Life Sciences Limited
- Wockhardt Limited
- Morepen Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 23 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.